Pharmagreen Biotech Stock Price Prediction
As of 18th of October 2025 the relative strength index (rsi) of Pharmagreen Biotech's share price is below 20 indicating that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Pharmagreen Biotech's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Pharmagreen Biotech, which may create opportunities for some arbitrage if properly timed.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Pharmagreen Biotech hype-based prediction, you can estimate the value of Pharmagreen Biotech from the perspective of Pharmagreen Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pharmagreen Biotech to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Pharmagreen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pharmagreen Biotech after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pharmagreen |
| Symbol | PHBI |
| Name | Pharmagreen Biotech |
| Type | Pink Sheet |
| Country | United States |
| Exchange | PINK |
Hype Analysis is not found for Pharmagreen Biotech at this timeWe are unable to locate Pharmagreen Biotech hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.Hype Analysis
Prediction analysis is currently not available
Other Suggestions
| PH | Parker Hannifin | Company |
| PHK | Pimco High Income | Fund |
| PHB | Invesco Fundamental High | ETF |
| PHB | PHB | Cryptocurrency |
Thematic Opportunities
Explore Investment Opportunities
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Pharmagreen Biotech Additional Predictive Modules
Most predictive techniques to examine Pharmagreen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharmagreen using various technical indicators. When you analyze Pharmagreen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pharmagreen Biotech Predictive Indicators
The successful prediction of Pharmagreen Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pharmagreen Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pharmagreen Biotech based on analysis of Pharmagreen Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pharmagreen Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pharmagreen Biotech's related companies.
Story Coverage note for Pharmagreen Biotech
The number of cover stories for Pharmagreen Biotech depends on current market conditions and Pharmagreen Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pharmagreen Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pharmagreen Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Pharmagreen Biotech Short Properties
Pharmagreen Biotech's future price predictability will typically decrease when Pharmagreen Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pharmagreen Biotech often depends not only on the future outlook of the potential Pharmagreen Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharmagreen Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 442.3 M | |
| Short Long Term Debt | 219.1 K | |
| Shares Float | 370 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Tools for Pharmagreen Pink Sheet
When running Pharmagreen Biotech's price analysis, check to measure Pharmagreen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagreen Biotech is operating at the current time. Most of Pharmagreen Biotech's value examination focuses on studying past and present price action to predict the probability of Pharmagreen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagreen Biotech's price. Additionally, you may evaluate how the addition of Pharmagreen Biotech to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |